Hims & Hers Health

Last updated
Hims & Hers Health, Inc.
Company type Public
Industry
Founded2017;7 years ago (2017)
Founders
Headquarters,
United States
Area served
Key people
  • Andrew Dudum (CEO)
  • Yemi Okupe (CFO)
  • Mike Chi (CGO)
  • Melissa Baird (COO) [4]
Products
Revenue
  • Increase2.svg US$872 million (2023) [6]
Website www.hims.com

Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.

Contents

Hims & Hers operates with a direct-to-consumer model. Consumers consult licensed healthcare professionals and access treatments and products through the company's platform. The company has expanded its offerings to include health solutions for both men and women, along with mental health services.

Founding, expansion, and public offering

Hims Inc. was established in 2017 by Jack Abraham, Andrew Dudum and Hilary Coles as a part of the Atomic Labs portfolio. [7] [1] In January 2019, Hims raised $100 million in a Series C funding round with a pre-money valuation of $1 billion. [8] [9] In the same month, Hims was launched in the United Kingdom with a catalogue limited by European regulation. [10]

Public offering

In October 2020, Hims closed a deal with Oaktree Capital Management to go public through a blank check company, reaching a valuation of $1.6 billion. [7] As part of the deal, the company was renamed Hims & Hers Health Inc. [11] The transaction was completed in January 2021, and the company started trading publicly on the New York Stock Exchange. [3]

Products and services

Hims initially sold erectile dysfunction treatment sildenafil and hair loss treatments such as minoxidil, biotin vitamins and DHT-blocking shampoo. [12] [13] [14] Hims launched Hers, a brand targeted to women, selling birth control pills and flibanserin in 2018. [7] [15] In 2020, Hims launched mental health services, including anonymous group therapy. [5]

In 2024, Hims announced it would add compounded GLP-1 injections to its product portfolio, giving customers a way to access weight loss treatment. [16]

Related Research Articles

Erectile dysfunction (ED), also referred to as impotence, is a form of sexual dysfunction in males characterized by the persistent or recurring inability to achieve or maintain a penile erection with sufficient rigidity and duration for satisfactory sexual activity. It is the most common sexual problem in males and can cause psychological distress due to its impact on self-image and sexual relationships.

<span class="mw-page-title-main">Sildenafil</span> Drug for erectile dysfunction and hypertension

Sildenafil, sold under the brand name Viagra, among others, is a medication used to treat erectile dysfunction and pulmonary arterial hypertension. It is also sometimes used off-label for the treatment of certain symptoms in secondary Raynaud's phenomenon. It is unclear if it is effective for treating sexual dysfunction in females. It can be taken orally, intravenously, or through the sublingual route. Onset when taken orally is typically within twenty minutes and lasts for about two hours.

<span class="mw-page-title-main">Tadalafil</span> Medication used to treat erectile dysfunction

Tadalafil, sold under the brand name Cialis among others, is a medication used to treat erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension. It is taken by mouth. Onset is typically within half an hour and the duration is up to 36 hours.

<span class="mw-page-title-main">Finasteride</span> Antiandrogen medication

Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used to treat pattern hair loss and benign prostatic hyperplasia (BPH) in men. It can also be used to treat excessive hair growth in women. It is usually taken orally but there are topical formulations for patients with hair loss, designed to minimize systemic exposure by acting specifically on hair follicles.

<span class="mw-page-title-main">Tim Ferriss</span> American entrepreneur, investor, author, and podcaster (born 1977)

Timothy Ferriss is an American entrepreneur, investor, author, podcaster, and lifestyle guru. He is known for his 4-Hour self-help book series—including The 4-Hour Work Week, The 4-Hour Body, and The 4-Hour Chef—that focused on lifestyle optimizations, but he has since reconsidered this approach. He also supports scientific research into psychedelic treatments.

<span class="mw-page-title-main">Avanafil</span> Chemical compound

Avanafil is a PDE5 inhibitor approved for erectile dysfunction by the FDA on April 27, 2012 and by EMA on June 21, 2013. Avanafil is sold under the brand names Stendra and Spedra. It was invented at Mitsubishi Tanabe Pharma, formerly known as Tanabe Seiyaku Co., and licensed to Vivus Inc., which partnered with Menarini Group to commercialise Spedra in over forty European countries, Australia, and New Zealand. Metuchen Pharmaceuticals obtained exclusive rights within the United States.

<span class="mw-page-title-main">Herbal viagra</span> Class of herbal products said to treat erectile dysfunction

Herbal viagra is a herbal product advertised as treating erectile dysfunction. Many different products are advertised as herbal viagra, but with varying ingredients. No clinical trials or scientific studies support the effectiveness of any of these ingredients for the treatment of erectile dysfunction and some products have been found to contain drugs and other adulterants, and have been the subject of FDA and FTC warnings and actions to remove them from the market.

KwikMed is an approved online pharmacy in the United States which has been granted regulatory approval to operate and sell medications online. Based in Salt Lake City, Utah, KwikMed's parent company, Phoenix Capital Management, is located in Scottsdale, Arizona. Specifically, KwikMed has been granted regulatory approval to prescribe medications for erectile dysfunction, male pattern hair loss and smoking cessation provided specific operating procedures are followed.

<span class="mw-page-title-main">Zocdoc</span> Online medical care appointment booking service

Zocdoc is a New York City-based company offering an online service that allows people to find and book in-person or telemedicine appointments for medical or dental care. The platform also functions as a physician and dentist rating and comparison database. The service is free for patients, and doctors pay to advertise their appointment slots. Established in 2007, the private company had a $1.8 billion valuation by August 2015, the third-highest for a startup in New York at the time.

Online doctor is a term that emerged during the 2000s, used by both the media and academics, to describe a generation of physicians and health practitioners who deliver healthcare, including drug prescription, over the internet.

Talkspace, Inc. is an online and mobile therapy company based in New York City. It was founded by Oren and Roni Frank in 2012. Talkspace users have access to licensed therapists through the website or mobile app on iOS and Android. Talkspace has been criticized for making questionable claims about its effectiveness, compromised user privacy, posted fake reviews to improve its rating in an app store, and uses freelance therapists of uncertain qualifications.

<span class="mw-page-title-main">Teladoc Health</span> American healthcare company

Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company headquartered in the United States. Primary services include telehealth, medical opinions, AI and analytics, telehealth devices and licensable platform services. In particular, Teladoc Health uses telephone and videoconferencing software as well as mobile apps to provide on-demand remote medical care.

Oscar Health, Inc. is an American health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company focuses on the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems which would make it easier for patients to navigate.

Clue is a menstrual health app developed by the Berlin-based technology company BioWink GmbH. The app has over 15 million users from 180 countries. The startup has raised over $17 million from backers that include Union Square Ventures and Mosaic Ventures.

<span class="mw-page-title-main">Cyrus Massoumi</span> American entrepreneur

Cyrus Massoumi is the founder of telehealth service Dr. B and the founder of the investment fund humbition. He is also the founder of Zocdoc and was the company CEO for eight years.

<span class="mw-page-title-main">Ro (company)</span> American telehealth company

Ro is an American telehealth company that diagnoses patients, and subsequently prescribes and delivers treatments. The company is headquartered in New York City.

Nuro, Inc. is an American robotics company based in Mountain View, California. Founded by Jiajun Zhu and Dave Ferguson, Nuro develops autonomous delivery vehicles and is the first company to receive an autonomous exemption from the National Highway Traffic Safety Administration.

This list of telemedicine services providers is for notable telemedicine, telehealth, and mobile health providers and services. This includes virtual care facilities for remote care, services or platforms used for specific steps within the healthcare industry, and clinical navigation.

Monument Inc. is a telemedicine company that provides online treatment for alcohol use disorder. It offers therapy and physician appointments as well as support groups entirely through video calls. Monument was founded in New York City in 2020 by Mike Russell. By 2023, it had at least 100,000 users registered.

LifeMD, Inc. is a publicly traded American telehealth company. It gives subscribers access to doctors and nurse practitioners for virtual medical consultations and treatments with prescription medications.

References

  1. 1 2 Khazan, Olga (6 June 2019). "You Can Buy Prescription Drugs Without Seeing a Doctor". The Atlantic. Retrieved 2 April 2021.
  2. Hims & Hers Health, Inc. (17 February 2021). "Hims & Hers Health, Inc. to Participate in Upcoming Investor Conference". BusinessWire. Retrieved 25 March 2021.
  3. 1 2 Loizos, Connie (21 January 2021). "Hims, the telehealth startup, saw its shares slip in their trading debut — and that's fine with its CEO". TechCrunch. Retrieved 25 March 2021.
  4. Primack, Dan (8 May 2019). "Online medicine site Hims nabs former Lyft marketing executive". Axios. Retrieved 2 April 2021.
  5. 1 2 Shieber, Jonathan (7 April 2021). "Hims launches group therapy services as first foray into broader mental health initiative". TechCrunch. Retrieved 2 April 2021.
  6. "Achieving Profitability and What Comes Next". Hims&Hers Newsroom. 26 February 2024. Retrieved 26 February 2024.
  7. 1 2 3 Brown, Kristen V.; De Vynck, Gerrit (30 October 2020). "Hims Built a $1.6 Billion Online Empire by Pushing Prescriptions". Bloomberg Businessweek. Retrieved 24 March 2021.
  8. Clark, Kate (29 January 2019). "Wellness startup Hims enters the unicorn club with $100M investment". TechCrunch. Retrieved 25 March 2021.
  9. Raphael, Rina (2 April 2019). "This "hair wellness" startup is taking on Rogaine". Fast Company. Retrieved 25 March 2021.
  10. Moshakis, Alex (17 March 2019). "Evolution of man: the rise and rise of the male wellness sector". The Observer. The Guardian. Retrieved 25 March 2021.
  11. Rinker, Brian (1 October 2020). "Telemedicine startup Hims to merge with blank check company Oaktree Acquisition Corp". San Francisco Business Times. Retrieved 25 March 2021.
  12. Hurly, Adam (5 December 2017). "Now You Can Subscribe to Hair Loss and Erectile Dysfunction Pills". GQ. Retrieved 25 March 2021.
  13. Schneier, Matthew (28 November 2017). "Finally Putting Some Fun in Erectile Dysfunction". The New York Times. Retrieved 25 March 2021.
  14. Budds, Diana (15 November 2017). "This Startup Is Rebranding Penis Pills And Hair Loss Treatments For Millennials". Fast Company. Retrieved 25 March 2021.
  15. Raphael, Rina (31 October 2018). "Hims launches Hers: Men's wellness startup now has a "badass sister"". Fast Company.
  16. Cerullo, Megan (21 May 2024). "Hims & Hers says it's selling a GLP-1 weight loss drug for 85% less than Wegovy. Here's the price". TechCrunch. Retrieved 13 June 2024.